|
Volumn 21, Issue 18, 2011, Pages 5557-5561
|
Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Ca v3.2) inhibitors
|
Author keywords
Ca v3.2; Calcium channel inhibition; T type calcium channels
|
Indexed keywords
CALCIUM CHANNEL BLOCKING AGENT;
CALCIUM CHANNEL T TYPE;
CALCIUM CHANNEL T TYPE CAV3.2 BLOCKING AGENT;
MIBEFRADIL;
N (1 ADAMANTYL) 2 (4 ALKYLPIPERAZIN 1 YL) ACETAMIDE DERIVATIVE;
POTASSIUM CHANNEL HERG;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANTIHYPERTENSIVE ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG CLEARANCE;
DRUG IDENTIFICATION;
DRUG METABOLISM;
DRUG POTENCY;
DRUG SYNTHESIS;
HUMAN;
IC 50;
MALE;
NONHUMAN;
RAT;
STRUCTURE ACTIVITY RELATION;
ACETAMIDES;
ANIMALS;
ANTIHYPERTENSIVE AGENTS;
CALCIUM CHANNELS, T-TYPE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DISCOVERY;
ETHER-A-GO-GO POTASSIUM CHANNELS;
HIGH-THROUGHPUT SCREENING ASSAYS;
HUMANS;
MOLECULAR STRUCTURE;
RATS;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
RATTUS;
|
EID: 80051928867
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2011.06.092 Document Type: Article |
Times cited : (7)
|
References (20)
|